| type="text/javascript"> ch_client = "articlealley"; | | | | expand their operations. |
| ch_type = "mpu"; ch_width = 590; ch_height = 250; | | | | Boost to clinical research trial companies |
| ch_non_contextual = 4; ch_noborders = 1; | | | | Of late, several global drug giants including Aventis, |
| ch_vertical ="premium"; ch_sid = "590x250 Article | | | | Pfizer, Novo Nordisk, Novartis and GlaxoSmithKline, |
| Mixed Top"; var ch_queries = new Array( ); var | | | | have started running clinical drug trials in India due to |
| th)); if ( ch_selected < ch_queries.length ) { | | | | the low-cost advantage and the huge patient pool. |
| ch_query = ch_queries[ch_selected]; } In the | | | | As a result, 20-30% of the global clinical development |
| present economic scenario, when most industry | | | | activity is rapidly outsourced to Clinical Research |
| verticals are witnessing a downward growth slide, the | | | | Organisations (CROs) in India. |
| biotech research and clinical trial industry in India is | | | | "Indian healthcare and biotech firms, conducting clinical |
| defying the trend and clocking an impressive growth. | | | | research trials, are witnessing a substantial rise in their |
| India is turning out to be one of the most preferred | | | | business due to the wide range of commercial |
| destinations for conducting global clinical research | | | | benefits they offer, such as hassle-free recruitment |
| trials. The number of clinical research projects that | | | | of patients and cost savings. Multinational drug |
| are being outsourced to Indian private small-scale | | | | companies are also entering India drawn by the rich |
| healthcare and biotech research organisations have | | | | pool of technically skilled manpower in the country," |
| gone up substantially in the past few years. The rise | | | | said K Vora, VP of SHRM Biotechnologies Private |
| in clinical trial research outsourcing to the Indian | | | | Limited, a mid-sized organisation offering extensive |
| healthcare and research organisations has encouraged | | | | consultancy services in the areas of |
| small players to ramp up their research activities and | | | | biopharmaceuticals and biotechnology. |